Understanding the heterogeneity of pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive, treatment-resistant cancer characterized by extensive inter- and intra-tumoral heterogeneity. Although over 95 % of cases harbor KRAS mutations and commonly altered tumor suppressors like TP53, SMAD4, and CDKN2A, these genetic changes a...

Full description

Bibliographic Details
Published in:Translational Oncology
Main Authors: Juan Iovanna, Nicolas Fraunhoffer, Raul Urrutia, Nelson Dusetti
Format: Article
Language:English
Published: Elsevier 2025-10-01
Subjects:
PDAC
Tumor heterogeneity
Metastases
Tumor progression
Tumor microenvironment
Epigenetics
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523325002104

Internet

http://www.sciencedirect.com/science/article/pii/S1936523325002104

Similar Items